Advertisement
Advertisement

RVMD

RVMD logo

Revolution Medicines, Inc. Common Stock

182.08
USD
Sponsored
+3.91
+2.19%
Jun 26, 16:00 UTC -4
Closed
exchange

After-Market

182.99

+0.91
+0.50%

Revolution Medicines, Inc. Common Stock Profile

About

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

Info & Links

CEO

Mark A. Goldsmith

Headquarters

700 Saginaw Drive
Redwood City, CA 94063, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.revmed.com

Auditor

PricewaterhouseCoopers LLP

Share holders

46

Employees

883

Revolution Medicines, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

38.90B

Enterprise Value

38.74B

Enterprise Value/EBITDA(ttm)

-27.86

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

11.40

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-63.10%

Return on Invested Capital(ttm)

-57.69%

Return on Assets(ttm)

-48.13%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-1.39B

Net Income Available to Common(ttm)

-1.37B

Diluted EPS(ttm)

-5.91

Share Statistics

Beta (5Y Monthly)

1.01

52-Week Change

374.04%

S&P 500 52-Week Change

19.75%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

212.60M

Dividend Yield

0.00%

Float4

181.92M

% Held by Insiders

8.20%

% Held by Institutions

94.34%

Balance Sheet

Total Cash(mrq)

1.91B

Total Cash Per Share(mrq)

8.98

Total Debt(mrq)

280.64M

Total Debt/Equity(mrq)

16.46%

Current Ratio(mrq)

7.14%

Quick Ratio(mrq)

7.14%

Book Value Per Share(mrq)

8.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.72

Free Cash Flow(ytd)

-913.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement